In a Dec 8 submission to the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC), pediatric rheumatologist J. Patrick Whelan, M.D., Ph.D., expressed concern that mRNA products, through spike proteins, have “the potential to cause microvascular injury [inflammation and small blood clots called microthrombi] to the brain, heart, liver and kidneys in ways that were not assessed in the safety trials.”
No comments:
Post a Comment